- Home
- TTOO
TTOO
T2 Biosystems Inc.
as 11-15-2024 4:00pm EST
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | 8.7M | IPO Year: | 2014 |
| Target Price: | $5.00 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.44 - $8.38 | Next Earning Date: | 11-14-2024 |
| Revenue: | $7,677,000 | Revenue Growth: | -30.19% |
| Revenue Growth (this year): | 50.31% | Revenue Growth (next year): | 117.92% |
Stock Insider Trading Activity of T2 Biosystems Inc. (TTOO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Elsbree David B | TTOO | Director | Sep 13 '24 | Sell | $2.42 | 55 | $133.10 | 23 |
Latest T2 Biosystems Inc. News
TTOO Breaking Stock News: Dive into TTOO Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 days ago
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
Associated Press Finance
3 days ago
T2 Biosystems: Q3 Earnings Snapshot
GlobeNewswire
3 days ago
T2 Biosystems Announces Third Quarter 2024 Financial Results
MT Newswires
9 days ago
T2 Biosystems Shares Fall After Company Receives Nasdaq Non-Compliance Notice
GlobeNewswire
12 days ago
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
Thomson Reuters StreetEvents
a month ago
Q3 2024 T2 Biosystems Inc Earnings Call
GuruFocus.com
a month ago
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
Zacks
a month ago
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
Compare TTOO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TTOO T2 Biosystems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.